Abstract: The present invention relates to a catalyst composition. More particularly, the present invention relates to a catalyst composition comprising a low SAR zeolite, copper in an amount of at least 2 wt %; and a rare earth element. The present invention also relates to a method for the manufacture of a catalyst composition. The present invention further relates to a catalyst article comprising a catalyst composition and a method for the treatment of an exhaust gas which comprises contacting an exhaust gas with a catalyst article comprising a catalyst composition.

Abstract: A photodetector interface circuit is described, residing partially or fully within a unit cell per pixel of an FPA. The interface circuit uses an innovative approach to providing pixel level digitization for full frame integration times while maintaining the ability to use integration capacitors of practical sizes. The technique uses successive charge subtraction, removing charge from an integration capacitor successively, triggered by the charge increasing sufficiently to charge the integrator to a reference level, thereby triggering both charge removal and incrementing a count, until all of the current flowing in the photodetector has been accounted for and the count represents the digitization of the photodetector signal. Various options on how to arrange the digitization elements are also disclosed.

Abstract: The invention concerns pharmaceutical compositions containing a hydrogen sulphate salt of 6-(4-bromo-2-chloro-phenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-carboxylic acid (2-hydroxy-ethoxy)-amide and solvates, crystalline forms and amorphous forms thereof, to the use of said compositions as a medicament; and to processes for the preparation of said compositions.

Abstract: The invention concerns pharmaceutical compositions containing a hydrogen sulphate salt of 6-(4-bromo-2-chloro-phenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-carboxylic acid (2-hydroxy-ethoxy)-amide and solvates, crystalline forms and amorphous forms thereof, to the use of said compositions as a medicament; and to processes for the preparation of said compositions.

Abstract: A system comprises a plurality of remote addressable devices being individually programmed with configuration data and emitting an output signal modulated to encode the configuration data such that the output signal includes a visual output signal and/or an audio output signal. The system further comprises a mobile device communicating with the plurality of remote addressable devices. The mobile device receives the output signal and demodulates it to extract the configuration data. The system further comprises a central controller communicating with the plurality of remote addressable devices.

Abstract: The present disclosure relates to medicament injection devices. An injection device includes: a movable dosage programming component comprising a rotary encoder system having a predefined angular periodicity, a sensor arrangement including a first optical sensor configured to detect movement of the movable dosage programming component relative to the sensor arrangement during dosing of a medicament, wherein the first optical sensor is configured to operate in a strobe-sampling mode at a first frequency, a second optical sensor configured to detect movement of the rotary encoder system relative to the second optical sensor wherein the second optical sensor is configured to operate in a strobe-sampling mode at a second frequency lower than the first frequency, and a processor arrangement configured to, based on the detected movement, determine a medicament dosage administered by the injection device.

Abstract: The present disclosure relates to adapter assemblies for use with and to electrically and mechanically interconnect electromechanical surgical devices and surgical reloads, and to surgical systems including handheld electromechanical surgical devices and adapter assemblies for connecting surgical reloads to the handheld electromechanical surgical devices.

Abstract: The present disclosure relates to adapter assemblies for use with and to electrically and mechanically interconnect electromechanical surgical devices and surgical reloads, and to surgical systems including handheld electromechanical surgical devices and adapter assemblies for connecting surgical reloads to the handheld electromechanical surgical devices.

Abstract: This disclosure is directed, at least in part, to AMPK activators useful for the treatment of conditions or disorders associated with AMPK. In some embodiments, the condition or disorder is associated with the gut-brain axis. In some embodiments, condition or disorder is associated with systemic infection and inflammation from having a leaky gut barrier. In some embodiments, the AMPK activators are gut-restricted compounds. In some embodiments, the AMPK activators are agonists or partial agonists.

Abstract: A supplemental device for attachment to an injection device, the supplemental device having a housing containing at least two electromechanical switches each having an open state and a closed state and a protrusion associated with each switch configured to protrude from the housing so as to contact a rotatable surface of the injection device while the supplemental device is attached to the injection device; and a processor arrangement configured to detect a change in the state of each of the switches; and to determine a direction of rotation of the rotatable surface of the injection device from the detected state changes.

Abstract: Example portable grills including a base having supports for storing removable side tables are disclosed. An example portable grill includes a cookbox, a base, and a side table. The base is coupled to the cookbox. The base is configured to support the cookbox above an underlying surface onto which the base is to be placed. The side table is configured to be removably coupled to the base in a storage position. The side table is to be located beneath the cookbox when the side table is coupled to the base in the storage position.

Abstract: The invention relates to an electronic module for recording information of a drug delivery device, the electronic module comprising at least one connector, wherein at least one connector is adapted to be connected to a port of the drug delivery device and wherein at least one connector is adapted to be connected to a port of a computer. Furthermore, the invention relates to a drug delivery device, comprising a port for connecting to the connector of the electronic module.

Abstract: The present disclosure relates to a method for forming a catalyst article comprising: (a) forming a plastic mixture having a solids content of greater than 50% by weight by mixing together a crystalline small pore or medium pore molecular sieve in an H+ or NH4+ form, an insoluble active metal precursor, an inorganic matrix component, an organic auxiliary agent, an aqueous solvent and optionally inorganic fibres; (b) moulding the plastic mixture into a shaped article; and (c) calcining the shaped article to form a solid catalyst body. The present disclosure further relates to a catalyst article, particularly a catalyst article which is suitable for use in the selective catalytic reduction of nitrogen oxides, and to an exhaust system.

Abstract: A coupling (2) is disclosed. The coupling (2) comprises an outer member (4), an inner member (8), an intermediate member (6) and a plurality of buffer elements (18, 20). The outer member (4) comprises a plurality of radially inward projections (10), the inner member (6) comprises a plurality of radially outward projections (16) and the intermediate member (6) comprises a plurality of radially inward projections (14) and a plurality of radially outward projections (12). The plurality of buffer elements (18, 20) are disposed between the projections (10, 12, 14, 16). The plurality of radially inward projections (10) of the outer member (4) and the plurality of radially outward projections (12) of the intermediate member (6) are radially overlapped, and the plurality of radially outward projections (16) of the inner member (6) and the plurality of radially inner projections (14) of the intermediate member (6) are radially overlapped.

Abstract: Example portable grills having reversible steam tray assemblies are disclosed. An example portable grill includes a cookbox, a heating element, a water pan, and a steam tray. The heating element is located within the cookbox. The water pan is located within the cookbox above the heating element. The water pan includes a bottom wall. The steam tray is located within the water pan. The steam tray includes a horizontally-oriented support wall having a plurality of openings extending therethrough. The steam tray is configured to be reversibly positioned within the water pan in a first orientation and a second orientation. The support wall is spaced from the bottom wall by a first distance when the steam tray is positioned in the first orientation. The support wall is spaced from the bottom wall by a second distance greater than the first distance when the steam tray is positioned in the second orientation.

Abstract: The present disclosure relates to medicament injection devices. An injection device includes: a movable dosage programming component comprising a rotary encoder system having a predefined angular periodicity, a sensor arrangement including a first optical sensor configured to detect movement of the movable dosage programming component relative to the sensor arrangement during dosing of a medicament, wherein the first optical sensor is configured to operate in a strobe-sampling mode at a first frequency, a second optical sensor configured to detect movement of the rotary encoder system relative to the second optical sensor wherein the second optical sensor is configured to operate in a strobe-sampling mode at a second frequency lower than the first frequency, and a processor arrangement configured to, based on the detected movement, determine a medicament dosage administered by the injection device.

Abstract: Various methods, apparatuses/systems, and media for providing IaC templates in a cloud environment are provided. A processor creates a plurality of IaC templates. Each of the plurality of IaC templates includes instructions to build at least a portion of an infrastructure. The plurality of IaC templates is stored in a central repository. The processor collects one or more of the plurality of the created IaC templates from the central repository in order to build a desired infrastructure package. The processor also executes at least one of updating, removing, upgrading, downgrading, and verifying the infrastructure package in the central repository. Each of the plurality of IaC templates also includes metadata identifying at least one of a package, installation instructions of the package, at least one dependency of the package, a version of the package, and a size of the package.

Abstract: A system includes a plurality of remote addressable devices, each remote addressable device of the plurality of remote addressable devices being individually programmed with configuration data of the respective addressable device. Each remote addressable device includes a radio frequency (RF) transceiver to transmit a RF signal encoded with an address and a physical location of the remote addressable device transmitting the RF signal. The system further includes a plurality of bases. Each base of the plurality of bases includes a RF sensor for receiving the RF signal from the RF transceiver of the corresponding remote addressable device subsequent to the remote addressable device being positioned in the base.

Abstract: The invention concerns pharmaceutical compositions containing a hydrogen sulphate salt of 6-(4-bromo-2-chloro-phenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-carboxylic acid (2-hydroxy-ethoxy)-amide and solvates, crystalline forms and amorphous forms thereof, to the use of said compositions as a medicament; and to processes for the preparation of said compositions.

Abstract: An electronic system comprising: at least one user interface member configured to be manipulated by a user for performing a dose setting operation of the drug delivery device and/or for performing a dose delivery operation for delivering a set dose, an electronic control unit configured to control operation of the electronic system, an electrical signaling unit configured to provide at least one electrical signal when the user interface member is manipulated, and a manipulation evaluation unit configured to evaluate the at least one electrical signal of the signaling unit to determine whether the manipulation of the user interface member indicated by the at least one signal of the signaling unit qualifies as an activation operation. The electronic control unit is configured to switch the electronic system into a higher power consumption when the manipulation evaluation unit has confirmed that the manipulation qualifies as activation operation.